-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
Total costs of sales and operating expenses for the period.
-
Summary
-
Iovance Biotherapeutics, Inc. quarterly/annual Costs and Expenses history and growth rate from 2021 to 2023.
- Iovance Biotherapeutics, Inc. Costs and Expenses for the quarter ending September 30, 2024 was $148M, a 24.2% increase year-over-year.
- Iovance Biotherapeutics, Inc. Costs and Expenses for the twelve months ending September 30, 2024 was $521M.
- Iovance Biotherapeutics, Inc. annual Costs and Expenses for 2023 was $462M, a 15.8% increase from 2022.
- Iovance Biotherapeutics, Inc. annual Costs and Expenses for 2022 was $399M, a 16.4% increase from 2021.
Costs and Expenses, Trailing 12 Months (USD)
Costs and Expenses, Annual (USD)
Costs and Expenses, YoY Annual Growth (%)